Related Experiment Videos
Tumor-specific gene expression
1Richard Dimbleby Department of Cancer Research, St Thomas' Hospital, London, UK.
Abstract:
For gene therapy to become a realistic treatment modality for cancer, it must be at least as effective and, importantly, less toxic than current regimes of radio- and chemotherapy. Therefore, the therapeutic gene(s) must only be delivered to, or expressed in, the appropriate target cells. Whilst delivery vehicles with tropisms restricted at the level of the tumor cell surface are still being developed, protocols have been devised which target gene expression specifically to tumor cells, whilst minimizing expression in surrounding cells. Such tumor-cell specific gene expression can be achieved by any combination of localized gene delivery, the use of vectors with selectivity for dividing cells and incorporation of specific transcriptional regulatory sequences to restrict gene expression predominantly to tumor cells.
Insights
Gene therapy for cancer requires targeted gene delivery and expression specifically in tumor cells to minimize toxicity. Strategies focus on localized delivery, dividing cell selectivity, and transcriptional regulation for safer cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Current cancer treatments like radio- and chemotherapy exhibit significant toxicity.
- Gene therapy offers a promising alternative but requires precise targeting to be effective and safe.
Purpose of the Study:
- To outline strategies for achieving tumor-specific gene expression in cancer gene therapy.
- To ensure gene therapy is less toxic than conventional cancer treatments.
Main Methods:
- Developing delivery vehicles with restricted tropisms to tumor cell surfaces.
- Implementing protocols for localized gene delivery.
- Utilizing vectors selective for dividing cells.
- Incorporating specific transcriptional regulatory sequences.
Main Results:
- Protocols have been devised to target gene expression specifically to tumor cells.
- Minimizing gene expression in surrounding healthy cells is achievable.
- Tumor-cell specific gene expression can be attained through combined strategies.
Conclusions:
- Achieving tumor-specific gene expression is crucial for advancing gene therapy in oncology.
- Combining localized delivery, cell-cycle targeting, and transcriptional control enhances safety and efficacy.
- These approaches pave the way for realistic and less toxic cancer gene therapy modalities.